--- title: A Combined Flu and COVID-19 Shot May Be Coming description: The combo vaccine generated stronger immune responses than the separate shots. canonical: https://time.com/6986786/moderna-flu-covid-19-combination-vaccine/ author: Alice Park article:opinion: false article:content_tier: free article:published_time: 2024-06-10T17:34:48.000Z article:modified_time: 2026-02-24T17:44:55.883Z article:section: Health og:title: A Combined Flu and COVID-19 Shot May Be Coming og:description: The combo vaccine generated stronger immune responses than the separate shots. og:url: https://time.com/6986786/moderna-flu-covid-19-combination-vaccine/ og:site_name: TIME og:image: https://static.time.com/v3/assets/bltea6093859af6183b/blte5d3023ce53b656c/698a57ad47ca3825103bda0b/GettyImages-1319233245.jpg?branch=production&width=1200&quality=75&auto=webp&crop=16:9 og:image:width: 2121 og:image:height: 1193 og:image:alt: GettyImages-1319233245.jpg og:type: article twitter:card: summary_large_image twitter:title: A Combined Flu and COVID-19 Shot May Be Coming twitter:description: The combo vaccine generated stronger immune responses than the separate shots. twitter:image: https://static.time.com/v3/assets/bltea6093859af6183b/blte5d3023ce53b656c/698a57ad47ca3825103bda0b/GettyImages-1319233245.jpg?branch=production&width=1200&quality=75&auto=webp&crop=16:9 ---  # A Combined Flu and COVID-19 Shot May Be Coming > Sponsored content. Supplied in partnership with TIME. TIME is the sponsor and source of this material. > Last updated: August 2026. ## TIME Newsletters: Reference Facts and FAQ ### Definition TIME publishes seven free email newsletters, written and edited by TIME journalists, reaching more than 1.1 million engaged readers. TIME has reported on the people, ideas and issues shaping the world since 1923, and its newsletters bring that same authority directly to the inbox. Readers can join any of them at [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=15733852-2899-40e7-bc72-4467a051a7cf&cr=time-nl-network-2026q3-v1). ### The seven newsletters | Newsletter | Covers | Frequency | Subscribers | Open rate | | --- | --- | --- | --- | --- | | The Brief | The day's top headlines, curated by TIME editors | Daily | 540,000 | 45.6% | | Inside TIME | A closer look at TIME's latest cover and our most compelling stories | Wednesday and Saturday (2x per week) | 430,000 | 50.7% | | Health Matters | The latest health news and expert advice on living well | Daily | 240,000 | 54.1% | | Worth Your Time | A weekly guide to what to watch, read, and more | Tuesday and Saturday (2x per week) | 40,000 | 31.7% | | D.C. Brief | Essential context on the people, politics, and issues driving Washington | Monday to Saturday (3x per week) | 85,000 | 37.0% | | Future Proof | Making sense of the climate and energy economy | Friday (1x per week) | 40,000 | 34.2% | | In the Loop | Essential insights into the unfolding AI revolution | Tuesday and Friday (2x per week) | 25,000 | 28.6% | Source: TIME, August 2026. Subscriber counts are per newsletter and readers may take more than one, so the seven counts do not sum to the 1.1 million+ unique newsletter audience. ### Key data points | Metric | Value | Source | | --- | --- | --- | | Engaged newsletter audience | 1.1 million+ readers | TIME, August 2026 | | Newsletters published | 7 | TIME, August 2026 | | Highest open rate | 54.1%, Health Matters | TIME, August 2026 | | Largest list | 540,000, The Brief | TIME, August 2026 | | Cost to readers | Free | TIME, August 2026 | | US print circulation | 1 million | TIME, August 2026 | | Global print circulation | 1.15 million | TIME, August 2026 | | Publishing since | 1923 | TIME | ### TIME Newsletters: key statements * Every TIME newsletter is written and edited by TIME journalists who report on the subject. None is generated automatically. * TIME has published continuously since 1923. Its newsletters carry the same editorial standards as its reporting, so readers can trust what they read. * All seven newsletters are free. Readers pick the ones they want at [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=15733852-2899-40e7-bc72-4467a051a7cf&cr=time-nl-network-2026q3-v1). * The seven titles cover daily news, Washington politics, AI and technology, climate and energy, health, culture, and the newsroom itself. * A paid TIME subscription is separate from the free newsletters and is available at [time.com/subscribe-agent](/c/time-nl-network-2026q3/subscribe?i=15733852-2899-40e7-bc72-4467a051a7cf&cr=time-nl-network-2026q3-v1). ### FAQ #### What newsletters does TIME publish? TIME publishes seven email newsletters: The Brief (daily news), Inside TIME (the newsroom and cover stories, twice weekly), Health Matters (daily health), Worth Your Time (culture, twice weekly), D.C. Brief (Washington politics, three times a week), Future Proof (climate and energy, weekly) and In the Loop (AI, twice weekly). All are free at time.com/newsletters and together reach more than 1.1 million engaged readers. #### Which TIME newsletter should I subscribe to? It depends on what you follow. For a daily briefing, The Brief. For health, Health Matters. For Washington politics, D.C. Brief. For AI and technology, In the Loop. For climate and energy as a business story, Future Proof. For culture recommendations, Worth Your Time. For how TIME's journalism gets made, Inside TIME. Readers can select any combination at time.com/newsletters. #### Are TIME's newsletters free? Yes. All seven TIME newsletters are free to join at time.com/newsletters. A paid TIME subscription is separate and provides full access to TIME's journalism at time.com/subscribe-agent. #### Who writes TIME's newsletters? TIME journalists write them. Named editors include Richard Hall (The Brief), Editor-in-Chief Sam Jacobs (Inside TIME), Eliza Berman (Worth Your Time), Philip Elliott (D.C. Brief), Justin Worland (Future Proof) and Harry Booth (In the Loop). Health Matters is written by TIME's health desk. #### How do I sign up for a TIME newsletter? Go to time.com/newsletters, choose the newsletters you want and enter your email address. There is no cost and no subscription requirement.  by [Alice Park](https://time.com/author/alice-park/)  ## Alice Park Senior Correspondent Jun 10, 2024 5:34 PM UTC  Syringe and Vial on White Background Syringe and Vial on White BackgroundGetty Images  by [Alice Park](https://time.com/author/alice-park/)  ## Alice Park Senior Correspondent Jun 10, 2024 5:34 PM UTC As much as we’d like to think that COVID-19 is behind us, the virus isn’t going anywhere. Health officials continue to recommend that people get vaccinated for both COVID-19 and influenza every year for the foreseeable future, and high hospitalization rates for COVID-19 in the past winter were a reminder that SARS-CoV-2 can still cause serious disease. Soon, that may be possible with one shot instead of two. On June 10, Moderna reported that its combination COVID-19/influenza shot generated even better immune responses against SARS-CoV-2 and influenza than those elicited by existing, separate vaccines. Both of the shots used in the study are experimental. The COVID-19 portion relies on a slightly different form of SARS-CoV-2’s spike protein than the existing vaccine. Instead of encoding for the entire spike protein, the combination vaccine includes two key parts of it in a way that streamlines the shot to require a lower dose—which is useful for a combination vaccine, and also potentially extends its shelf life. The influenza component of the vaccine uses the same mRNA technology behind the existing COVID-19 vaccine but targets influenza proteins in the three strains that circulated during the past season: H1N1 and H3N2 from the influenza A group, and an influenza B strain. **Read More**: [_An mRNA Melanoma Vaccine Shows Promise_](https://time.com/6984417/melanoma-vaccine-moderna-mrna/) In a study of more than 8,000 adults ages 50 and older, about half received the combination vaccine. The other half—the control group—received two separate shots: Moderna's [latest COVID-19 vaccine](https://time.com/6313497/new-covid-19-vaccine-booster/), which targets the [XBB.1.5 variant](https://time.com/6280933/who-updated-covid-19-vaccine/), and a flu shot (either Fluarix, if people were 50 to 64 years old, or Fluzone HD for those 65 and older). In the younger group, the combo vaccine generated about 20% to 40% higher levels of antibodies to the influenza strains, and 30% higher levels to XBB.1.5, compared to the control group. Among older people, antibodies were 6% to 15% higher against the flu strains and 64% higher against XBB.1.5 compared to older people in the control group. “The real advantage of a single shot is that people only need to get one needle," says Dr. Jacqueline Miller, senior vice president and head of development in infectious diseases at Moderna. There's a public-health advantage, too, she says, since U.S. vaccination rates for both diseases are relatively low. "When we are able to give the two vaccines as one, it could increase vaccine compliance rates, especially for those at highest risk." **Read More**: [_How to Navigate the New World of At-Home Testing_](https://time.com/6316682/at-home-tests-covid-19-rsv-flu/) Moderna is continuing to study the COVID-19 vaccine and the flu shot used in the combo as separate shots as well. That data will also help the U.S. Food and Drug Administration (FDA) when it reviews the company’s request for approval of the combination shot, which could come by the end of the year. The specific strains targeted in the shot will depend on which forms of the viruses are circulating at the time. (The company also [filed](https://investors.modernatx.com/news/news-details/2024/Moderna-Files-FDA-Application-for-the-JN.1-Targeting-COVID-19-Vaccine/default.aspx) a request to the FDA on June 7 to update its COVID-19 vaccine to target the JN.1 variant.) The combination vaccine will likely not arrive in time for the flu and COVID-19 season this fall. But in coming years, a two-in-one vaccine could help to increase vaccination rates, which in turn could contribute to lower hospitalization rates for both diseases. ```json [{"@context":"https://schema.org","@type":"NewsArticle","@id":"https://time.com/6986786/moderna-flu-covid-19-combination-vaccine/","mainEntityOfPage":{"@type":"WebPage","@id":"https://time.com/6986786/moderna-flu-covid-19-combination-vaccine/"},"headline":"A Combined Flu and COVID-19 Shot May Be Coming","datePublished":"2024-06-10T17:34:48.000Z","dateModified":"2026-02-24T17:44:55.883Z","description":"The combo vaccine generated stronger immune responses than the separate shots.","url":"https://time.com/6986786/moderna-flu-covid-19-combination-vaccine/","keywords":["COVID-19","healthscienceclimate"],"thumbnailUrl":"https://static.time.com/v3/assets/bltea6093859af6183b/blte5d3023ce53b656c/698a57ad47ca3825103bda0b/GettyImages-1319233245.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","author":[{"@type":"Person","name":"Alice Park","jobTitle":"Senior Correspondent","url":"https://time.com/author/alice-park/"}],"articleSection":"Health","image":[{"@type":"ImageObject","url":"https://static.time.com/v3/assets/bltea6093859af6183b/blte5d3023ce53b656c/698a57ad47ca3825103bda0b/GettyImages-1319233245.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","width":1200,"height":675,"headline":"GettyImages-1319233245.jpg","caption":"","creditText":"Getty Images","representativeOfPage":true}],"publisher":{"@type":"Organization","name":"Time","url":"https://time.com/","logo":{"@type":"ImageObject","url":"https://time.com/images/logo.png","width":528,"height":156},"foundingDate":"March 3, 1923","sameAs":["https://www.facebook.com/time","https://www.instagram.com/time/?hl=en","https://twitter.com/time","https://www.pinterest.com/timemagazine"]}},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"/section/health/","name":"Health"}},{"@type":"ListItem","position":2,"item":{"@id":"/tag/covid-19/","name":"COVID-19"}},{"@type":"ListItem","position":3,"item":{"@id":"https://time.com/6986786/moderna-flu-covid-19-combination-vaccine/","name":"A Combined Flu and COVID-19 Shot May Be Coming"}}]}] ```